Global CRISPR And CRISPR-Associated (Cas) Genes Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Report Id

46131

Publisher Name

Global Info Research

Published Date

2/19/2019

No of Pages

119

Market Scenario

Clustered regularly interspaced short palindromic repeats (CRISPR) are segments of prokaryotic DNA containing short repetitions of base sequences. Each repetition is followed by short segments of "spacer DNA" from previous exposures to a bacteriophage virus or plasmid. The CRISPR/Cas system is a prokaryotic immune system that confers resistance to foreign genetic elements such as those present within plasmids and phages, and provides a form of acquired immunity. CRISPR associated proteins (Cas) use the CRISPR spacers to recognize and cut these exogenous genetic elements in a manner analogous to RNA interference in eukaryotic organisms. CRISPRs are found in approximately 40% of sequenced bacterial genomes and 90% of sequenced archaea. Scope of the Report: CRISPR And CRISPR-Associated (Cas) Genes industry is relatively concentrated, manufacturers are mostly in the Europe and North America. Among them, North America region accounted for more than 45.70% of the total market of global CRISPR And CRISPR-Associated (Cas) Genes. Although this market has great potential for future development, we do not recommend entering the market for investors who do not have strong capital or do not have key technology. The worldwide market for CRISPR And CRISPR-Associated (Cas) Genes is expected to grow at a CAGR of roughly 39.8% over the next five years, will reach 2640 million US$ in 2024, from 350 million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the CRISPR And CRISPR-Associated (Cas) Genes in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers Caribou Biosciences Addgene CRISPR THERAPEUTICS Merck KGaA Mirus Bio LLC Editas Medicine Takara Bio USA Thermo Fisher Scientific Horizon Discovery Group Intellia Therapeutics GE Healthcare Dharmacon Market Segment by Regions, regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Colombia etc.) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Market Segment by Type, covers Genome Editing Genetic engineering gRNA Database/Gene Librar CRISPR Plasmid Human Stem Cells Genetically Modified Organisms/Crops Cell Line Engineering Market Segment by Applications, can be divided into Biotechnology Companies Pharmaceutical Companies Academic Institutes Research and Development Institutes The content of the study subjects, includes a total of 15 chapters: Chapter 1, to describe CRISPR And CRISPR-Associated (Cas) Genes product scope, market overview, market opportunities, market driving force and market risks. Chapter 2, to profile the top manufacturers of CRISPR And CRISPR-Associated (Cas) Genes, with price, sales, revenue and global market share of CRISPR And CRISPR-Associated (Cas) Genes in 2017 and 2018. Chapter 3, the CRISPR And CRISPR-Associated (Cas) Genes competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast. Chapter 4, the CRISPR And CRISPR-Associated (Cas) Genes breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019. Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019. Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019. Chapter 12, CRISPR And CRISPR-Associated (Cas) Genes market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024. Chapter 13, 14 and 15, to describe CRISPR And CRISPR-Associated (Cas) Genes sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

Table of Contents 1 Market Overview 1.1 CRISPR And CRISPR-Associated (Cas) Genes Introduction 1.2 Market Analysis by Type 1.2.1 Genome Editing 1.2.2 Genetic engineering 1.2.3 gRNA Database/Gene Librar 1.2.4 CRISPR Plasmid 1.2.5 Human Stem Cells 1.2.6 Genetically Modified Organisms/Crops 1.2.7 Cell Line Engineering 1.3 Market Analysis by Applications 1.3.1 Biotechnology Companies 1.3.2 Pharmaceutical Companies 1.3.3 Academic Institutes 1.3.4 Research and Development Institutes 1.4 Market Analysis by Regions 1.4.1 North America (United States, Canada and Mexico) 1.4.1.1 United States Market States and Outlook (2014-2024) 1.4.1.2 Canada Market States and Outlook (2014-2024) 1.4.1.3 Mexico Market States and Outlook (2014-2024) 1.4.2 Europe (Germany, France, UK, Russia and Italy) 1.4.2.1 Germany Market States and Outlook (2014-2024) 1.4.2.2 France Market States and Outlook (2014-2024) 1.4.2.3 UK Market States and Outlook (2014-2024) 1.4.2.4 Russia Market States and Outlook (2014-2024) 1.4.2.5 Italy Market States and Outlook (2014-2024) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 1.4.3.1 China Market States and Outlook (2014-2024) 1.4.3.2 Japan Market States and Outlook (2014-2024) 1.4.3.3 Korea Market States and Outlook (2014-2024) 1.4.3.4 India Market States and Outlook (2014-2024) 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024) 1.4.4 South America, Middle East and Africa 1.4.4.1 Brazil Market States and Outlook (2014-2024) 1.4.4.2 Egypt Market States and Outlook (2014-2024) 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024) 1.4.4.4 South Africa Market States and Outlook (2014-2024) 1.4.4.5 Turkey Market States and Outlook (2014-2024) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 Caribou Biosciences 2.1.1 Business Overview 2.1.2 CRISPR And CRISPR-Associated (Cas) Genes Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 Caribou Biosciences CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.2 Addgene 2.2.1 Business Overview 2.2.2 CRISPR And CRISPR-Associated (Cas) Genes Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 Addgene CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.3 CRISPR THERAPEUTICS 2.3.1 Business Overview 2.3.2 CRISPR And CRISPR-Associated (Cas) Genes Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 CRISPR THERAPEUTICS CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.4 Merck KGaA 2.4.1 Business Overview 2.4.2 CRISPR And CRISPR-Associated (Cas) Genes Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 Merck KGaA CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.5 Mirus Bio LLC 2.5.1 Business Overview 2.5.2 CRISPR And CRISPR-Associated (Cas) Genes Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 Mirus Bio LLC CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.6 Editas Medicine 2.6.1 Business Overview 2.6.2 CRISPR And CRISPR-Associated (Cas) Genes Type and Applications 2.6.2.1 Product A 2.6.2.2 Product B 2.6.3 Editas Medicine CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.7 Takara Bio USA 2.7.1 Business Overview 2.7.2 CRISPR And CRISPR-Associated (Cas) Genes Type and Applications 2.7.2.1 Product A 2.7.2.2 Product B 2.7.3 Takara Bio USA CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.8 Thermo Fisher Scientific 2.8.1 Business Overview 2.8.2 CRISPR And CRISPR-Associated (Cas) Genes Type and Applications 2.8.2.1 Product A 2.8.2.2 Product B 2.8.3 Thermo Fisher Scientific CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.9 Horizon Discovery Group 2.9.1 Business Overview 2.9.2 CRISPR And CRISPR-Associated (Cas) Genes Type and Applications 2.9.2.1 Product A 2.9.2.2 Product B 2.9.3 Horizon Discovery Group CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.10 Intellia Therapeutics 2.10.1 Business Overview 2.10.2 CRISPR And CRISPR-Associated (Cas) Genes Type and Applications 2.10.2.1 Product A 2.10.2.2 Product B 2.10.3 Intellia Therapeutics CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.11 GE Healthcare Dharmacon 2.11.1 Business Overview 2.11.2 CRISPR And CRISPR-Associated (Cas) Genes Type and Applications 2.11.2.1 Product A 2.11.2.2 Product B 2.11.3 GE Healthcare Dharmacon CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 3 Global CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018) 3.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales and Market Share by Manufacturer (2017-2018) 3.2 Global CRISPR And CRISPR-Associated (Cas) Genes Revenue and Market Share by Manufacturer (2017-2018) 3.3 Market Concentration Rate 3.3.1 Top 3 CRISPR And CRISPR-Associated (Cas) Genes Manufacturer Market Share in 2018 3.3.2 Top 6 CRISPR And CRISPR-Associated (Cas) Genes Manufacturer Market Share in 2018 3.4 Market Competition Trend 4 Global CRISPR And CRISPR-Associated (Cas) Genes Market Analysis by Regions 4.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Market Share by Regions 4.1.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales and Market Share by Regions (2014-2019) 4.1.2 Global CRISPR And CRISPR-Associated (Cas) Genes Revenue and Market Share by Regions (2014-2019) 4.2 North America CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2014-2019) 4.3 Europe CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2014-2019) 4.4 Asia-Pacific CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2014-2019) 4.5 South America CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2014-2019) 4.6 Middle East and Africa CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2014-2019) 5 North America CRISPR And CRISPR-Associated (Cas) Genes by Country 5.1 North America CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Market Share by Country 5.1.1 North America CRISPR And CRISPR-Associated (Cas) Genes Sales and Market Share by Country (2014-2019) 5.1.2 North America CRISPR And CRISPR-Associated (Cas) Genes Revenue and Market Share by Country (2014-2019) 5.2 United States CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2014-2019) 5.3 Canada CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2014-2019) 5.4 Mexico CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2014-2019) 6 Europe CRISPR And CRISPR-Associated (Cas) Genes by Country 6.1 Europe CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Market Share by Country 6.1.1 Europe CRISPR And CRISPR-Associated (Cas) Genes Sales and Market Share by Country (2014-2019) 6.1.2 Europe CRISPR And CRISPR-Associated (Cas) Genes Revenue and Market Share by Country (2014-2019) 6.2 Germany CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2014-2019) 6.3 UK CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2014-2019) 6.4 France CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2014-2019) 6.5 Russia CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2014-2019) 6.6 Italy CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2014-2019) 7 Asia-Pacific CRISPR And CRISPR-Associated (Cas) Genes by Country 7.1 Asia-Pacific CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Market Share by Country 7.1.1 Asia-Pacific CRISPR And CRISPR-Associated (Cas) Genes Sales and Market Share by Country (2014-2019) 7.1.2 Asia-Pacific CRISPR And CRISPR-Associated (Cas) Genes Revenue and Market Share by Country (2014-2019) 7.2 China CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2014-2019) 7.3 Japan CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2014-2019) 7.4 Korea CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2014-2019) 7.5 India CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2014-2019) 7.6 Southeast Asia CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2014-2019) 8 South America CRISPR And CRISPR-Associated (Cas) Genes by Country 8.1 South America CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Market Share by Country 8.1.1 South America CRISPR And CRISPR-Associated (Cas) Genes Sales and Market Share by Country (2014-2019) 8.1.2 South America CRISPR And CRISPR-Associated (Cas) Genes Revenue and Market Share by Country (2014-2019) 8.2 Brazil CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2014-2019) 8.3 Argentina CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2014-2019) 8.4 Colombia CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2014-2019) 9 Middle East and Africa CRISPR And CRISPR-Associated (Cas) Genes by Countries 9.1 Middle East and Africa CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Market Share by Country 9.1.1 Middle East and Africa CRISPR And CRISPR-Associated (Cas) Genes Sales and Market Share by Country (2014-2019) 9.1.2 Middle East and Africa CRISPR And CRISPR-Associated (Cas) Genes Revenue and Market Share by Country (2014-2019) 9.2 Saudi Arabia CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2014-2019) 9.3 Turkey CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2014-2019) 9.4 Egypt CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2014-2019) 9.5 Nigeria CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2014-2019) 9.6 South Africa CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2014-2019) 10 Global CRISPR And CRISPR-Associated (Cas) Genes Market Segment by Type 10.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Market Share by Type (2014-2019) 10.1.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales and Market Share by Type (2014-2019) 10.1.2 Global CRISPR And CRISPR-Associated (Cas) Genes Revenue and Market Share by Type (2014-2019) 10.2 Genome Editing Sales Growth and Price 10.2.1 Global Genome Editing Sales Growth (2014-2019) 10.2.2 Global Genome Editing Price (2014-2019) 10.3 Genetic engineering Sales Growth and Price 10.3.1 Global Genetic engineering Sales Growth (2014-2019) 10.3.2 Global Genetic engineering Price (2014-2019) 10.4 gRNA Database/Gene Librar Sales Growth and Price 10.4.1 Global gRNA Database/Gene Librar Sales Growth (2014-2019) 10.4.2 Global gRNA Database/Gene Librar Price (2014-2019) 10.5 CRISPR Plasmid Sales Growth and Price 10.5.1 Global CRISPR Plasmid Sales Growth (2014-2019) 10.5.2 Global CRISPR Plasmid Price (2014-2019) 10.6 Human Stem Cells Sales Growth and Price 10.6.1 Global Human Stem Cells Sales Growth (2014-2019) 10.6.2 Global Human Stem Cells Price (2014-2019) 10.7 Genetically Modified Organisms/Crops Sales Growth and Price 10.7.1 Global Genetically Modified Organisms/Crops Sales Growth (2014-2019) 10.7.2 Global Genetically Modified Organisms/Crops Price (2014-2019) 10.8 Cell Line Engineering Sales Growth and Price 10.8.1 Global Cell Line Engineering Sales Growth (2014-2019) 10.8.2 Global Cell Line Engineering Price (2014-2019) 11 Global CRISPR And CRISPR-Associated (Cas) Genes Market Segment by Application 11.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Application (2014-2019) 11.2 Biotechnology Companies Sales Growth (2014-2019) 11.3 Pharmaceutical Companies Sales Growth (2014-2019) 11.4 Academic Institutes Sales Growth (2014-2019) 11.5 Research and Development Institutes Sales Growth (2014-2019) 12 CRISPR And CRISPR-Associated (Cas) Genes Market Forecast (2019-2024) 12.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Growth Rate (2019-2024) 12.2 CRISPR And CRISPR-Associated (Cas) Genes Market Forecast by Regions (2019-2024) 12.2.1 North America CRISPR And CRISPR-Associated (Cas) Genes Market Forecast (2019-2024) 12.2.2 Europe CRISPR And CRISPR-Associated (Cas) Genes Market Forecast (2019-2024) 12.2.3 Asia-Pacific CRISPR And CRISPR-Associated (Cas) Genes Market Forecast (2019-2024) 12.2.4 South America CRISPR And CRISPR-Associated (Cas) Genes Market Forecast (2019-2024) 12.2.5 Middle East and Africa CRISPR And CRISPR-Associated (Cas) Genes Market Forecast (2019-2024) 12.3 CRISPR And CRISPR-Associated (Cas) Genes Market Forecast by Type (2019-2024) 12.3.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales Forecast by Type (2019-2024) 12.3.2 Global CRISPR And CRISPR-Associated (Cas) Genes Market Share Forecast by Type (2019-2024) 12.4 CRISPR And CRISPR-Associated (Cas) Genes Market Forecast by Application (2019-2024) 12.4.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales Forecast by Application (2019-2024) 12.4.2 Global CRISPR And CRISPR-Associated (Cas) Genes Market Share Forecast by Application (2019-2024) 13 Sales Channel, Distributors, Traders and Dealers 13.1 Sales Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.1.3 Marketing Channel Future Trend 13.2 Distributors, Traders and Dealers 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology 15.2 Data Source

Methodology

This research report involves complete picture of the market with the help of in-depth secondary and primary research. This research report studies several aspects of the market and analyze vital industry influencers. Extensive secondary research has been conducted using paid as well as open access data sources in order to gather information on the market and parent market. These key findings are then analyzed and validated with the help of in-house data models and primary discussions with key industry participants and experts across the value chain

research-methodology

Research Tools and Models

  • Top-Down Approach and Bottom-Up Approach
  • QFD Modeling for Market Size and Share Calculation
  • Regression, Variable and Impact Analysis
  • Penetration Modeling

Qualitative Research

  • It comprises briefing about market dynamics and business opportunities and strategies.
  • Finally, all the research findings are validated through interviews with in-house industry experts, freelance consultants and key opinion leaders etc.

Quantitative Research

It involves various mathematical tools, models, projection, and sampling techniques. It involves following steps:

  • Identification of market variables and market size derivation
  • Assessment of future prospects, opportunities and market penetration rates by analyzing product commercialization, regional trends etc.
  • Evaluation historical market trends and derivation of present and future year-on-year growth trends

Fill below details to get free sample !!

Contact Us
Call Now